ClinicalTrials.gg
CompletedNCT01344265Updated Apr 4, 2013

The Correlation Between B-type Natriuretic Peptide (BNP) and Global End Diastolic Volume

An observational study in Critically Ill, sponsored by Jinhua Central Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2013-04-04.

Sponsored by Jinhua Central Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
46
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The investigators hypothesized that the serum B-type Natriuretic Peptide (BNP) level may be correlated with global end diastolic volume (GEDV) as measured by transpulmonary thermodilution technique (PiCCO). The rationale is that some animal studies have proven that BNP is released from ventricular myocardium in response to physical expansion. Such physical expansion can be measured by GEDV. If the hypothesis can be confirmed with our study, the serum level BNP can be used to monitor volume status of critically ill patient, instead of the invasive monitoring system.

02

Conditions studied

  • Critically Ill

Browse trials for

Keywords

  • B-type natriuretic peptide
  • global end diastolic volume
03

In context

Critical Illness

1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.

This study's enrollment of 46 is below the median of 140 across 816 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Jinhua Central Hospital is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

critically ill patients who required hemodynamic monitoring using PiCCO

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • critically ill patients who required hemodynamic monitoring using PiCCO

Exclusion criteria

Exclusion Criteria:

  • patients with renal dysfunction
  • those older than 80 years
  • pregnant women
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
46 participants (actual)

Groups and cohorts

  • consecutive patients

    there is only one group in our study

06

What researchers measure

Primary outcomes

  1. global end diastolic volume

    this is measured by transpulmonary thermodilution technique

    Time frame: within 12 h after measurement of BNP

07

Study locations

1 site
  • Jinhua central hospital
    Jinhua, Zhejiang 321000, China
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2010, a primary completion of Oct 2011 and a completion of Oct 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2011
First posted
Apr 29, 2011
Start
Jun 2010
Primary completionActual
Oct 2011
CompletionActual
Oct 2011
Last update
Apr 4, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 4, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01344265
Lead sponsor
Jinhua Central Hospital
Responsible party
Zhongheng Zhang (Dr., Jinhua Central Hospital) — Principal investigator
First posted
Apr 29, 2011
Start date
Jun 2010
Primary completion
Oct 2011
Completion
Oct 2011
Last update
Apr 4, 2013

Study contacts

Zhongheng Zhang, MD
study chair · Jinhua Central Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion